Trial Profile
CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2011
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Heart disorders; Hyperlipidaemia
- Focus Biomarker; Therapeutic Use
- Acronyms CREATE
- 30 Jun 2011 New trial record